Brandon Lam

1.2k total citations
34 papers, 766 citations indexed

About

Brandon Lam is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Brandon Lam has authored 34 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 12 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Brandon Lam's work include Immunotherapy and Immune Responses (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Brandon Lam is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Brandon Lam collaborates with scholars based in United States, South Korea and Australia. Brandon Lam's co-authors include Joseph Larkin, Kenneth Lau, Chien‐Fu Hung, Emily Farmer, Meina Liang, Yeong-Min Park, Andrew Yang, Young Seob Kim, Tae Heung Kang and T.‐C. Wu and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Brandon Lam

33 papers receiving 748 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brandon Lam United States 13 325 270 149 93 82 34 766
Liat Stoler‐Barak Israel 17 585 1.8× 373 1.4× 145 1.0× 41 0.4× 89 1.1× 30 1.1k
Sabrina Jutz Austria 13 344 1.1× 169 0.6× 300 2.0× 52 0.6× 61 0.7× 15 673
Christine Häfner Austria 23 228 0.7× 326 1.2× 205 1.4× 142 1.5× 66 0.8× 65 1.2k
Samuel J. S. Rubin United States 15 232 0.7× 365 1.4× 160 1.1× 60 0.6× 33 0.4× 31 823
Mahdi Shabani Iran 16 197 0.6× 334 1.2× 157 1.1× 88 0.9× 36 0.4× 55 798
Marcus Gereke Germany 17 623 1.9× 215 0.8× 243 1.6× 59 0.6× 153 1.9× 30 1.1k
Nahum Puebla‐Osorio United States 19 366 1.1× 469 1.7× 314 2.1× 49 0.5× 96 1.2× 43 1.0k
Jingying Zhou China 16 308 0.9× 303 1.1× 281 1.9× 145 1.6× 112 1.4× 51 1.0k
Ida H. Hiemstra Netherlands 16 390 1.2× 193 0.7× 324 2.2× 138 1.5× 41 0.5× 29 846
Hossein Asgarian‐Omran Iran 22 637 2.0× 347 1.3× 311 2.1× 57 0.6× 80 1.0× 106 1.3k

Countries citing papers authored by Brandon Lam

Since Specialization
Citations

This map shows the geographic impact of Brandon Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandon Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandon Lam more than expected).

Fields of papers citing papers by Brandon Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandon Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandon Lam. The network helps show where Brandon Lam may publish in the future.

Co-authorship network of co-authors of Brandon Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Brandon Lam. A scholar is included among the top collaborators of Brandon Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandon Lam. Brandon Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lam, Brandon, et al.. (2024). Profiling of VEGF Receptors and Immune Checkpoints in Recurrent Respiratory Papillomatosis. The Laryngoscope. 134(6). 2819–2825. 4 indexed citations
2.
Sano, Kaori, Brandon Lam, Katharina Röltgen, et al.. (2023). Detection of SARS-CoV-2 Antibodies in Immunoglobulin Products. The Journal of Allergy and Clinical Immunology In Practice. 11(8). 2534–2541.e2. 8 indexed citations
3.
Lam, Brandon, John C. Lin, Claire Y.‐H. Huang, et al.. (2023). In situ vaccination via tissue-targeted cDC1 expansion enhances the immunogenicity of chemoradiation and immunotherapy. Journal of Clinical Investigation. 134(1). 12 indexed citations
4.
Asrani, Kaushal, Juhyung Woo, Adrianna A. Mendes, et al.. (2022). An mTORC1-mediated negative feedback loop constrains amino acid-induced FLCN-Rag activation in renal cells with TSC2 loss. Nature Communications. 13(1). 6808–6808. 26 indexed citations
5.
Lam, Brandon, et al.. (2022). Localization of Salmonella and albumin-IL-2 to the tumor microenvironment augments anticancer T cell immunity. Journal of Biomedical Science. 29(1). 57–57. 12 indexed citations
6.
Lam, Brandon, John Lin, Louise Ferrall, et al.. (2021). Development of a Novel Mouse Model of Spontaneous High-Risk HPVE6/E7–Expressing Carcinoma in the Cervicovaginal Tract. Cancer Research. 81(17). 4560–4569. 16 indexed citations
7.
Lam, Brandon, et al.. (2021). Mass Spectrometry-Cleavable Protein N-Terminal Tagging Strategy for System-Level Protease Activity Profiling. Journal of the American Society for Mass Spectrometry. 33(1). 189–197. 1 indexed citations
8.
Lam, Brandon, et al.. (2021). Suppressor of cytokine signaling-1 mimetic peptides attenuate lymphocyte activation in the MRL/lpr mouse autoimmune model. Scientific Reports. 11(1). 6354–6354. 15 indexed citations
9.
Lam, Brandon, et al.. (2021). Delivery of IL-2 to the T Cell Surface Through Phosphatidylserine Permits Robust Expansion of CD8 T Cells. Frontiers in Immunology. 12. 755995–755995. 5 indexed citations
10.
Lam, Brandon, John Lin, Li Liu, et al.. (2021). A novel pseudovirus‐based mouse model of SARS-CoV-2 infection to test COVID-19 interventions. Journal of Biomedical Science. 28(1). 34–34. 20 indexed citations
11.
Lam, Brandon, et al.. (2021). Harmine inhibits breast cancer cell migration and invasion by inducing the degradation of Twist1. PLoS ONE. 16(2). e0247652–e0247652. 28 indexed citations
12.
Anchoori, Ravi, Brandon Lam, Samarjit Das, et al.. (2021). Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitors. PLoS ONE. 16(9). e0256937–e0256937. 6 indexed citations
13.
Feng, Po‐Hao, et al.. (2020). NKG2D-Fc fusion protein promotes antitumor immunity through the depletion of immunosuppressive cells. Cancer Immunology Immunotherapy. 69(10). 2147–2155. 10 indexed citations
14.
Kang, Tae Heung, Chih‐Ping Mao, Young Seob Kim, et al.. (2019). TLR9 acts as a sensor for tumor-released DNA to modulate anti-tumor immunity after chemotherapy. Journal for ImmunoTherapy of Cancer. 7(1). 260–260. 41 indexed citations
15.
Asrani, Kaushal, Sanjana Murali, Brandon Lam, et al.. (2019). mTORC1 feedback to AKT modulates lysosomal biogenesis through MiT/TFE regulation. Journal of Clinical Investigation. 129(12). 5584–5599. 31 indexed citations
16.
Iglesias, Marcos, et al.. (2018). Type-I Interferons Inhibit Interleukin-10 Signaling and Favor Type 1 Diabetes Development in Nonobese Diabetic Mice. Frontiers in Immunology. 9. 1565–1565. 10 indexed citations
17.
Ouyang, Guoqing, Li Xiong, Zhipeng Liu, et al.. (2018). Inhibition of autophagy potentiates the apoptosis-inducing effects of photodynamic therapy on human colon cancer cells. Photodiagnosis and Photodynamic Therapy. 21. 396–403. 37 indexed citations
18.
Shimmon, Ronald, et al.. (2016). Synthesis and organic impurity profiling of 4-methoxymethamphetamine hydrochloride and its precursors. Forensic Science International. 272. 184–189. 2 indexed citations
19.
Weppelmann, Thomas A., Michael E. von Fricken, Brandon Lam, et al.. (2016). Sparse serological evidence of Plasmodium vivax transmission in the Ouest and Sud-Est departments of Haiti. Acta Tropica. 162. 27–34. 8 indexed citations
20.
Liang, Meina, Scott L. Klakamp, Hong Lü, et al.. (2007). Detection of High- and Low-Affinity Antibodies Against a Human Monoclonal Antibody Using Various Technology Platforms. Assay and Drug Development Technologies. 5(5). 655–662. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liat Stoler‐Barak Breakdown of academic impact, for papers by Sabrina Jutz Breakdown of academic impact, for papers by Christine Häfner Breakdown of academic impact, for papers by Samuel J. S. Rubin Breakdown of academic impact, for papers by Mahdi Shabani Breakdown of academic impact, for papers by Marcus Gereke Breakdown of academic impact, for papers by Nahum Puebla‐Osorio Breakdown of academic impact, for papers by Jingying Zhou Breakdown of academic impact, for papers by Ida H. Hiemstra Breakdown of academic impact, for papers by Hossein Asgarian‐Omran
Rankless by CCL
2026